Style | Citing Format |
---|---|
MLA | Khayatan D, et al.. "Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases." Inflammopharmacology, vol. 33, no. 4, 2025, pp. 1583-1616. |
APA | Khayatan D, Razavi SM, Arab ZN, Nasoori H, Fouladi A, Pasha AVK, Butler AE, Karav S, Momtaz S, Abdolghaffari AH, Sahebkar A (2025). Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases. Inflammopharmacology, 33(4), 1583-1616. |
Chicago | Khayatan D, Razavi SM, Arab ZN, Nasoori H, Fouladi A, Pasha AVK, Butler AE, et al.. "Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases." Inflammopharmacology 33, no. 4 (2025): 1583-1616. |
Harvard | Khayatan D et al. (2025) 'Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases', Inflammopharmacology, 33(4), pp. 1583-1616. |
Vancouver | Khayatan D, Razavi SM, Arab ZN, Nasoori H, Fouladi A, Pasha AVK, et al.. Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases. Inflammopharmacology. 2025;33(4):1583-1616. |
BibTex | @article{ author = {Khayatan D and Razavi SM and Arab ZN and Nasoori H and Fouladi A and Pasha AVK and Butler AE and Karav S and Momtaz S and Abdolghaffari AH and Sahebkar A}, title = {Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases}, journal = {Inflammopharmacology}, volume = {33}, number = {4}, pages = {1583-1616}, year = {2025} } |
RIS | TY - JOUR AU - Khayatan D AU - Razavi SM AU - Arab ZN AU - Nasoori H AU - Fouladi A AU - Pasha AVK AU - Butler AE AU - Karav S AU - Momtaz S AU - Abdolghaffari AH AU - Sahebkar A TI - Targeting Mtor With Curcumin: Therapeutic Implications for Complex Diseases JO - Inflammopharmacology VL - 33 IS - 4 SP - 1583 EP - 1616 PY - 2025 ER - |